Dr. Nic an Riogh discusses bladder outlet obstruction in women
In this edition, Dr. Aisling Nic an Riogh (IE), a member of the EAU Guidelines panel for Non-neurogenic female LUTS, discusses bladder outlet obstruction (BOO) in women. Dr. Nic an Riogh defines blad...
10 Jan 202414min
UROONCO RCC take home message for 2023
In this podcast, UROONCO RCC board members, chief editor Dr. Carmen Mir (ES), and associate editors Dr. Riccardo Bertolo (IT) and Dr. Teele Kuusk (GB), discuss the progress made in the field of kidney...
27 Des 202318min
Special series: Assoc. Prof. Şener and Dr. Pietropaolo talk about networking and building professional relationships in urology
In 'Episode 4' of the series "What do young urologists need to know," 'Segment 1' covers the topic of "Navigating the transition from residency to professional urology practice." Assoc. Prof. Emre Şen...
17 Des 202311min
Special series: Dr. Seguí-Moya talks with Prof. Brookman-May about preparing for a job interview
This is 'Episode 3' of the podcast series "What do young urologists need to know," 'Segment 1': "Navigating the transition from residency to professional urology practice." Dr. Elena Seguí-Moya (GB) c...
10 Des 202323min
Special series: Dr. Rai and Dr. Kamphuis talk about preparing and keeping your CV updated
In 'Episode 2' of the series on "What young urologists need to know," segment 1 covers the topic of "Navigating the transition from residency to professional urology practice." Dr. Bhavan Prasad Rai (...
2 Des 202310min
Special series: Ms. Moreno-Fontela and Assoc. Prof. Kasivisvanathan discuss the significant transition after residency
In 'Episode 1' of the series on "What young urologists need to know," segment 1 covers the topic of "Navigating the transition from residency to professional urology practice." Assoc. Prof. Veeru Kasi...
25 Nov 202323min
Prof. James Catto (GB) shares results of THOR-2 cohort 1 study
In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks with Prof. James Catto (GB) about the THOR-2 cohort 1 study: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo...
12 Nov 20237min
Dr. Agarwal shares LITESPARK-013 results: Optimal dose of belzutifan is 120mg
In this podcast, Dr. Neeraj Agarwal (US), presidential endowed chair of cancer research at the Huntsman Cancer Institute, University of Utah, shares the results of the LITESPARK-013 Phase 2 trial - "S...
8 Nov 20234min
